Logo image of MGRX

MANGOCEUTICALS INC (MGRX) Stock Fundamental Analysis

NASDAQ:MGRX - Nasdaq - US56270V2051 - Common Stock - Currency: USD

2.88  -0.11 (-3.68%)

Fundamental Rating

1

MGRX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of MGRX have multiple concerns. MGRX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MGRX had negative earnings in the past year.
MGRX had a negative operating cash flow in the past year.
MGRX Yearly Net Income VS EBIT VS OCF VS FCFMGRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -2M -4M -6M -8M

1.2 Ratios

MGRX's Return On Assets of -63.05% is on the low side compared to the rest of the industry. MGRX is outperformed by 97.50% of its industry peers.
MGRX's Return On Equity of -69.65% is on the low side compared to the rest of the industry. MGRX is outperformed by 82.50% of its industry peers.
Industry RankSector Rank
ROA -63.05%
ROE -69.65%
ROIC N/A
ROA(3y)-384.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MGRX Yearly ROA, ROE, ROICMGRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -200 -400 -600 -800 -1K

1.3 Margins

MGRX's Gross Margin of 58.60% is amongst the best of the industry. MGRX outperforms 95.00% of its industry peers.
The Profit Margin and Operating Margin are not available for MGRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGRX Yearly Profit, Operating, Gross MarginsMGRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 -5K -10K -15K -20K

More info and screens

2

2. Health

2.1 Basic Checks

MGRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MGRX has been increased compared to 1 year ago.
MGRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MGRX Yearly Shares OutstandingMGRX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 500K 1M
MGRX Yearly Total Debt VS Total AssetsMGRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 200K 400K 600K 800K 1M

2.2 Solvency

MGRX has an Altman-Z score of 0.21. This is a bad value and indicates that MGRX is not financially healthy and even has some risk of bankruptcy.
MGRX has a Altman-Z score of 0.21. This is amonst the worse of the industry: MGRX underperforms 90.00% of its industry peers.
MGRX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
MGRX has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. MGRX outperforms 85.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC9.22%
MGRX Yearly LT Debt VS Equity VS FCFMGRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -2M -4M -6M

2.3 Liquidity

MGRX has a Current Ratio of 0.07. This is a bad value and indicates that MGRX is not financially healthy enough and could expect problems in meeting its short term obligations.
MGRX's Current ratio of 0.07 is on the low side compared to the rest of the industry. MGRX is outperformed by 97.50% of its industry peers.
A Quick Ratio of 0.07 indicates that MGRX may have some problems paying its short term obligations.
MGRX has a Quick ratio of 0.07. This is amonst the worse of the industry: MGRX underperforms 97.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
MGRX Yearly Current Assets VS Current LiabilitesMGRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 200K 400K 600K 800K

More info and screens

1

3. Growth

3.1 Past

MGRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1021.59%.
The Revenue has grown by 52.20% in the past year. This is a very strong growth!
EPS 1Y (TTM)-1021.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-778.45%
Revenue 1Y (TTM)52.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-45.6%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGRX Yearly Revenue VS EstimatesMGRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 200K 400K 600K
MGRX Yearly EPS VS EstimatesMGRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MGRX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGRX Price Earnings VS Forward Price EarningsMGRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGRX Per share dataMGRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MGRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MANGOCEUTICALS INC

NASDAQ:MGRX (1/27/2025, 11:38:47 AM)

2.88

-0.11 (-3.68%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.64%
Inst Owner Change0%
Ins Owners36.2%
Ins Owner Change0.23%
Market Cap8.87M
AnalystsN/A
Price TargetN/A
Short Float %1.76%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.75
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5.88
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.76
FCFYN/A
OCF(TTM)-1.76
OCFYN/A
SpS0.25
BVpS4.35
TBVpS-0.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -63.05%
ROE -69.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.6%
FCFM N/A
ROA(3y)-384.79%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z 0.21
F-Score3
WACC9.22%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1021.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-778.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.2%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-45.6%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-403.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-419.66%
OCF growth 3YN/A
OCF growth 5YN/A